Search for more clinical trials
Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning
Conditions
Breast Lesions - Breast Cyst - Early-Stage Breast Cancer - Benign Growth, Breast
Conditions: official terms
Breast Cyst
Conditions: Keywords
screening, compositional analysis, metabolism, breast, breast cyst, breast infection, breast inflammation, lipoma, benign growth, Women without a diagnosis for a region of interest in the breast
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
The purposes of this study is to establish normal optical values of breast tissue in the general population. This will allow for establishing normals for breast composition, and is expected to be useful in the classification of breast lesions into groups such as cysts, benign growths, inflammatory lesions, and possibly early breast cancer.
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: 50 Years
Minimum Age: 21 Years
Gender: Female
Criteria: Inclusion Criteria:
- You must be female
- You must be 21 to 50 years old
- You must not have or have had breast cancer.
- You must not have or have had breast implants or breast surgery
- You must not have had a breast biopsy or injury, or a breast infection, in 90 days.
Exclusion Criteria:
- Any one or more of the above conditions not met
- Lack of informed consent
- You must be female
- You must be 21 to 50 years old
- You must not have or have had breast cancer.
- You must not have or have had breast implants or breast surgery
- You must not have had a breast biopsy or injury, or a breast infection, in 90 days.
Exclusion Criteria:
- Any one or more of the above conditions not met
- Lack of informed consent
Location
Spectros Corporation
Portola Valley, California, United States
Status: Recruiting
Contact: Lizzy van Thillo, AA - 650-851-4040 - lizzy@spectros.com
Start Date
April 2008
Completion Date
April 2011
Sponsors
Spectros Corporation
Source
Spectros Corporation
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page